RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)

CUSIP: 75382E109

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
+713,161
Put/Call ratio
2.2%
SEC-reported price per share
$16.62
Indexed holders
96
Value change
+$11,319,522
Number of buys
42
Open additional details 1 more signal available
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,725,634

Security key

75382E109

Report period

Q3 2023

Indexed institutions

96

Top holders

10

Ownership snapshot

Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Peter Svennilson
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5 13F Highest disclosed value: $65,222,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $65.22M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
Peter Svennilson $56.8K
PRICE T ROWE ASSOCIATES INC /MD/ $65.22M
Column Group LLC $50.13M
PERCEPTIVE ADVISORS LLC $42.79M
BlackRock Finance, Inc. $40.66M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Peter Svennilson
3/4/5
Director, 10%+ Owner
—
denominator unverified
$56,850
7,500 shares
— 28 May 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$65,222,000
3,487,753 shares
— 30 Jun 2023
Column Group LLC
13F
Company
13F
—
denominator unverified
$50,127,613
2,680,621 shares
— 30 Jun 2023
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$42,794,819
2,288,493 shares
— 30 Jun 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$40,662,103
2,174,444 shares
— 30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$36,407,947
1,946,949 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
96
Shares
34,763,427
Indexed holders
96
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 indexed holders
97
Q3 2023 indexed holders
96
Indexed holder difference
-1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .